ADLM Spotlight

Seegene Inc., a global leader in multiplex PCR diagnostics, introduces CURECA™, a fully automated PCR platform offering true end-to-end automation from sample loading to result interpretation.

Sebia is a global leader in specialized in vitro diagnostics, providing instruments and reagents for screening and monitoring diseases in Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathies, Autoimmune and Infectious diseases, and other rare disorders.

Polymedco’s mission is to save lives through early detection of life-threatening diseases like colorectal cancer and cardiac diseases by partnering with healthcare systems, payors, providers, and reference labs to build effective screening and early detection programs.

Meet HORIBA in Chicago at the 2025 ADLM, Booth #328. HORIBA designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories.

HemoSonics’ Quantra® Hemostasis System is revolutionizing bleeding management with its next-generation whole-blood viscoelastic analyzer.

Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. Powered by key brands, including Erie Scientific, Menzel-Gläser, Microm, Shandon, and Richard-Allan Scientific,

ARKRAY has a long-standing history with fully automated urine chemistry and sediment analysis. Hundreds of urinalysis systems are placed throughout the USA. The new ARKRAY AUTION Bridge (AUTION Eye AI-4510 + AUTION Max AX-4060) is a fully automated, walk

ARK Diagnostics, Inc. is committed to improving health care through the design, development, manufacture and distribution of in vitro diagnostic (IVD) immunoassays for therapeutic drug monitoring (TDM), urine drug testing (UDT) and other small molecules. Our focus is the production of high quality, convenient, cost-effective products for routine use in research and clinical practice.